(Q61651684)

English

PHASE I STUDY OF AN ENGINEERED AGLYCOSYLATED HUMANIZED CD3 ANTIBODY IN RENAL TRANSPLANT REJECTION1

scientific article published on 01 December 1999

Statements

Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit